Clinical Trial Update: Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating efficacy and safety for allergic rhinitis/conjunctivitis; trial status terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinoconjunctivitis
• Perennial Allergic Rhinitis

Snippet

Sponsor: Inmunotek S.L. | Conditions: Allergic Rhinoconjunctivitis, Perennial Allergic Rhinitis | Phase 3 | Status: TERMINATED